sterile_table

TL3 Regular · Dortmund, DE

Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.

Joined 24 January 2025 · last posted 1d · groups: pharmacists

148 posts, newest first. Showing up to 150.

Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #123 · Evidence › Journal club · 27 Jul 2026 · 0 likes Post #122 put the caveat in the right place and I want to underline it. A methods point on SUSTAIN 6 rather than a substantive one: if the comparison is not like for…
PCOS and metabolic overlap: what is and is not studied Replied, post #4 · Clinical › Comorbidities · 27 Jul 2026 · 12 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
Selection into a registry and what it does to the estimate — a second dataset Replied, post #31 · Evidence › Study critique · 25 Jul 2026 · 6 likes Post #27 put the caveat in the right place and I want to underline it. Trying to state the Selection position in a way that someone who disagrees would recognise as…
What I would want from a home test that does not exist yet — what changed since Replied, post #105 · Analytics › Home & field testing · 22 Jul 2026 · 15 likes Research-use-only material is not certified for anything by anybody, and no home procedure changes that. What home checks buy you is early detection of the obvious…
The headache that turns out to be dehydration — the long version Replied, post #71 · Nutrition & Training › Hydration & electrolytes · 22 Jul 2026 · 0 likes Post #69 and I disagree about the size of the effect, not about the direction. Commercial rehydration formulations are designed for a specific purpose and are not…
Which categories are strict and which are relaxed, honestly Replied, post #33 · Start Here › Welcome · 20 Jul 2026 · 9 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #114 · Outcomes › Body composition · 14 Jul 2026 · 2 likes Post #111 put the caveat in the right place and I want to underline it. The version of Lean mass preservation that circulates here is a simplification of a…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #79 · Analytics › Home & field testing · 12 Jul 2026 · 26 likes Confirming post #76 from a second method, which matters more than confirming it from a second person. I would call the community position on consumer-accessible tests…
Request: tag synonyms surfaced in search Replied, post #16 · Meta › Feature requests · 11 Jul 2026 · 14 likes Taking post #15 at face value and following it one step further. The reason tag synonyms surfaced in search is hard to answer is that the obvious measurement and the…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #27 · Analytics › HPLC & UHPLC · 11 Jul 2026 · 8 likes On post #23 — agreed on the reasoning, with one qualification. On integration: where the baseline is drawn matters more than most people realise. On a clean…
Here for the analytics and not much else Replied, post #15 · Lounge › Introductions · 10 Jul 2026 · 2 likes Introductions are also a reasonable place to say what you are hoping to find, because somebody will usually know whether it exists here already.
Follow-up: How compounding permissions changed when supply normalised Replied, post #4 · Sourcing › Regulatory · 9 Jul 2026 · 9 likes The opening post answers the question as asked. The question underneath it is different. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound…
Why the timeline is on the right and not the left — what changed since Replied, post #70 · Meta › Site feedback · 8 Jul 2026 · 0 likes Confirming post #69 from a second method, which matters more than confirming it from a second person. Reframing timeline slightly, because I think the disagreement is…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #39 · Compounds › Secretagogues & GH axis · 8 Jul 2026 · 6 likes Nobody has said the unglamorous part of GHRH analogues versus ghrelin mimetics yet, so: most of the variation is explained by things that are boring to write about and…
When a dose reduction is the correct response to a side effect Replied, post #35 · Practice › Dosing & titration · 2 Jul 2026 · 27 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #57 · Sourcing › Independent verification · 1 Jul 2026 · 32 likes Answering the question post #55 raises rather than the one it answers. Asking the supplier before publishing a discrepancy is the convention here. Most discrepancies…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #30 · Practice › Dosing & titration · 1 Jul 2026 · 25 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
A site rotation scheme that is easy enough to actually follow Replied, post #101 · Practice › Administration · 29 Jun 2026 · 0 likes Everything in post #99 holds. The case it does not cover is the one I have. Since site rotation scheme keeps coming up, it should probably be a maintained page rather…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #84 · Analytics › HPLC & UHPLC · 28 Jun 2026 · 0 likes Carryover is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Carryover and the ghost peak from last week's standard — what changed since Replied, post #67 · Analytics › HPLC & UHPLC · 24 Jun 2026 · 18 likes Injection volume matters because column overload distorts peak shape, and an overloaded main peak can swallow a small neighbour. A certificate without injection volume…
Primary endpoint hierarchies and why order matters — one year on Replied, post #23 · Evidence › Trials · 23 Jun 2026 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Second pass at: Absence of evidence and evidence of absence Replied, post #27 · Research Methods › Statistics · 21 Jun 2026 · 0 likes Fair, and the limits you put on it are the part I will remember.
Pancreatitis history and the risk calculus Replied, post #21 · Safety › Contraindications · 21 Jun 2026 · 3 likes Two people in this thread mean different things by pancreatitis history and are disagreeing about the definition while believing they are disagreeing about the facts.…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #119 · Practice › Reconstitution · 20 Jun 2026 · 21 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. I would treat…
MS/MS sequence confirmation: what it costs and when it is worth it Replied, post #3 · Analytics › Mass spectrometry · 18 Jun 2026 · 0 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
What to include when your question involves a chromatogram — one year on Replied, post #38 · Start Here › How to Ask · 15 Jun 2026 · 18 likes Do not apologise in the first line. It costs you the space where the question should be, and nobody here thinks a question is an imposition. That matches what I was…
Request: a per-category review queue Replied, post #35 · Meta › Feature requests · 13 Jun 2026 · 1 like Counter-request, gently: please do not add anything on hover. It does not exist on a phone and half the readers here are on one. Stating my assumptions rather than…
Micronutrient adequacy at low total intake Replied, post #79 · Nutrition & Training › Protein & intake · 13 Jun 2026 · 8 likes Taking post #78 at face value and following it one step further. Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain…
Official shortage notices and what they authorise Replied, post #103 · Access › Shortages · 13 Jun 2026 · 0 likes I had written a reply contradicting post #101 and deleted it. Here is what survived. Both are useful and different. The notice tells you the national position; the…
Injection volume, overload, and peak distortion Replied, post #44 · Analytics › HPLC & UHPLC · 10 Jun 2026 · 2 likes I had written a reply contradicting post #42 and deleted it. Here is what survived. My experience of injection volume contradicts the reply above. I am posting it as a…
The anatomy of a question that gets answered within an hour Replied, post #72 · Start Here › How to Ask · 9 Jun 2026 · 2 likes On post #68 — agreed on the reasoning, with one qualification. Quantities without units are the single commonest reason a question sits unanswered. "Two and a half" is…
Does dual agonism explain the effect size, or is it dose? Replied, post #15 · Compounds › Tirzepatide · 4 Jun 2026 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #74 · Data & Tools › Datasets · 2 Jun 2026 · 18 likes Building on post #71 rather than restating it. A dataset is only useful if the collection method is described alongside it. Numbers without a protocol are a list rather…
Peak-to-trough ratio at steady state for a weekly agent Replied, post #23 · Pharmacology › Pharmacokinetics · 31 May 2026 · 2 likes Adding thanks rather than a view. I do not have a view worth the space.
The best-written scientific paper you have read Replied, post #71 · Lounge › Off topic · 29 May 2026 · 11 likes Genuine question rather than a rhetorical one: has anyone here actually observed best-written scientific paper, as opposed to read about it? The thread is long and I…
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #26 · Compounds › Retatrutide · 23 May 2026 · 0 likes I read post #22 twice before replying, because I had assumed the opposite. Two claims get bundled together under TRIUMPH and they need separating. The descriptive one —…
[2026 update] Thyroid function tests during substantial weight change Replied, post #71 · Clinical › Bloodwork · 18 May 2026 · 10 likes That is a fair summary of where the discussion has got to.
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #23 · Analytics › Method validation · 16 May 2026 · 0 likes Narrowing post #21, because the general version has more than one answer. Robustness testing deliberately varies the parameters most likely to drift — organic…
Anaesthesia and elective surgery: the aspiration question Replied, post #116 · Practice › Interactions · 8 May 2026 · 9 likes An update on my earlier anaesthesia and elective surgery post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
What I would want from a home test that does not exist yet — what changed since Replied, post #11 · Analytics › Home & field testing · 4 May 2026 · 10 likes I had written a reply contradicting post #7 and deleted it. Here is what survived. Colorimetric tests: colour intensity correlates with concentration, but the…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #16 · Compounds › Tirzepatide · 2 May 2026 · 9 likes Everything in post #12 holds. The case it does not cover is the one I have. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #22 · Practice › Administration · 2 May 2026 · 26 likes Leave real distance between consecutive sites rather than moving a centimetre. Repeatedly injecting one area changes the local tissue over time and eventually changes…
Transporting a vial for a weekend away — a second dataset Replied, post #35 · Practice › Storage & stability · 23 Apr 2026 · 3 likes Confirming post #32 from a second method, which matters more than confirming it from a second person. On Transporting a vial: the maintained page in the documentation…
Interim analyses and stopping rules Replied, post #19 · Evidence › Trials · 11 Apr 2026 · 2 likes The reason interim analyses and stopping rules keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the…
Revisiting: Drawing up with one needle and injecting with another Replied, post #46 · Practice › Administration · 5 Apr 2026 · 12 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. Adding…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #37 · Practice › Administration · 24 Mar 2026 · 10 likes Confirming post #34 from a second method, which matters more than confirming it from a second person. Leave real distance between consecutive sites rather than moving a…
Pharmacy supply in the UK and the questions you will be asked Replied, post #89 · Regional › UK & Ireland · 24 Mar 2026 · 1 like Availability through a private route and availability through the public system are separate questions and both change independently.
Preprint servers and what screening they do Replied, post #98 · Evidence › Preprints · 22 Mar 2026 · 7 likes A note on scope: what I am saying about preprint servers applies to the case in the first post and I would not extend it further without checking.
Follow-up: Levothyroxine timing: a real interaction with a simple fix Replied, post #4 · Practice › Interactions · 20 Mar 2026 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. Supplements and herbs: many have no established interaction. Some do. If you are…
Which fields on a certificate actually matter, ranked Replied, post #12 · Analytics › COA interpretation · 14 Mar 2026 · 0 likes Picking up post #9: that is the part I would want checked first. The distinction between release testing and characterisation is one industrial documents make and…
Second pass at: Identical chromatograms across two different lots Replied, post #59 · Sourcing › Red flags · 12 Mar 2026 · 0 likes On post #57 — agreed on the reasoning, with one qualification. A stock listing that never changes and a lead time that never varies are both worth noticing. Real…
Oral versus injected administration claims for BPC-157 Replied, post #5 · Compounds › Repair & healing peptides · 10 Mar 2026 · 4 likes Worth separating two things that post #3 runs together. Small correction to my own earlier position on oral versus injected administration claims. I had the units the…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #13 · Practice › Administration · 9 Mar 2026 · 1 like Completing a dose is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #2 · Compounds › Repair & healing peptides · 6 Mar 2026 · 13 likes The opening post is right about the mechanism and I think understates the practical bit. BPC-157: the preclinical literature is extensive, mostly from a small number of…
The most useful thing you learned here that was not the answer you came for Replied, post #25 · Lounge › Off topic · 6 Mar 2026 · 0 likes Analytics first, in my case, and I still find the practice category the harder read. Chromatography has one right answer more often than logistics does.
An ABAB design with a data table and honest limitations — a second dataset Replied, post #34 · Research Methods › N-of-1 designs · 4 Mar 2026 · 32 likes Post #33 is the version of this I will quote in future. One addition. Adding the boring version of ABAB design, because the interesting version keeps getting posted and…
Measurement error in a self-reported exposure Replied, post #80 · Evidence › Study critique · 25 Feb 2026 · 5 likes Quietly grateful for the plain phrasing. Not every thread gets that.
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 25 Feb 2026 · 18 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #57 · Practice › Interactions · 24 Feb 2026 · 25 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #29 · Practice › Administration · 21 Feb 2026 · 30 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #6 · Practice › Administration · 16 Feb 2026 · 0 likes A new needle for each injection is not fussiness. A needle blunts on first use and a blunted needle is the reason the second injection hurts more than the first. I…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #112 · Access › International · 16 Feb 2026 · 0 likes Answering the question post #109 raises rather than the one it answers. A regional experience posted here should say which year it describes. The archive keeps these…
Amylin receptor signalling and satiety — what changed since Replied, post #20 · Pharmacology › Receptor biology · 23 Jan 2026 · 4 likes The arithmetic in post #19 is right; the assumption feeding it is the part to check. GLP-1 receptor agonism produces its metabolic effects through more than one route:…
Angle of injection and whether 90 degrees is always right Replied, post #86 · Practice › Administration · 21 Jan 2026 · 1 like I had read the opposite somewhere and cannot now find where, which tells me something.
A history of disordered eating: proceeding carefully Replied, post #67 · Wellbeing › Mental health · 20 Jan 2026 · 1 like The practical version of history of disordered eating is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #10 · Evidence › Journal club · 18 Jan 2026 · 0 likes Everything in post #8 holds. The case it does not cover is the one I have. Reading back through the SURMOUNT-1 threads from last year, the same three questions come up…
Follow-up: Lyophilisation and why the cake looks the way it does Started this topic · Pharmacology › Formulation chemistry · 14 Jan 2026 · 14 likes Lyophilisation and why the cake looks the way it does Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about…
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #7 · Evidence › Trials · 13 Jan 2026 · 10 likes Before the thread moves on from Non-inferiority margins — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an…
Pharmacy supply in the UK and the questions you will be asked Replied, post #7 · Regional › UK & Ireland · 10 Jan 2026 · 9 likes Post #5 answers the question as asked. The question underneath it is different. I changed my mind about pharmacy supply after someone here asked me for the source and I…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #55 · Access › Pricing · 6 Jan 2026 · 25 likes A price well below the rest of the market is a fact rather than a finding, and it is worth noting without concluding from it. I would be glad to be shown a cleaner way…
Dead volume across syringe and needle combinations Replied, post #50 · Devices › Syringes & needles · 6 Jan 2026 · 32 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
A payment that went through twice: how it was resolved Replied, post #13 · Sourcing › Payments · 2 Jan 2026 · 0 likes Taking post #10 at face value and following it one step further. Refund policy before ordering: ask what the policy is if you receive damaged material or if the order…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #9 · Practice › Side effects · 1 Jan 2026 · 19 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
Vomiting: when it is expected and when it is a reason to stop Replied, post #88 · Practice › Side effects · 29 Dec 2025 · 20 likes I had written a reply contradicting post #86 and deleted it. Here is what survived. The published rates come from populations that were titrated on a defined schedule…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #80 · Compounds › Semaglutide · 29 Dec 2025 · 12 likes I read post #76 twice before replying, because I had assumed the opposite. On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with…
How to ask about something you suspect is a bad idea Replied, post #33 · Start Here › How to Ask · 11 Dec 2025 · 9 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #35 · Data & Tools › Calculators · 11 Dec 2025 · 2 likes What would change my mind on Feature request is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so…
Specification in the result column: why that is a meaningful error Replied, post #82 · Analytics › COA interpretation · 2 Dec 2025 · 11 likes Answering the question post #78 raises rather than the one it answers. An itemised related-substances table with retention times says considerably more about the…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #4 · Sourcing › Red flags · 1 Dec 2025 · 14 likes Supplier is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Heterogeneity as information rather than as a nuisance Replied, post #8 · Evidence › Meta-analyses · 25 Nov 2025 · 0 likes On heterogeneity I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads…
Reading SURMOUNT-1 without the press release — one year on Replied, post #24 · Compounds › Tirzepatide · 23 Nov 2025 · 1 like SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
Meeting a protein target on a suppressed appetite Replied, post #37 · Nutrition & Training › Protein & intake · 23 Nov 2025 · 0 likes Where intake has fallen a long way, protein is usually the first thing to fall because it is the least appealing macronutrient when appetite is reduced.
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #19 · Analytics › Impurities & related substances · 17 Nov 2025 · 0 likes I would call the community position on Aggregates likely rather than established, and I would be comfortable defending that hedge.
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #85 · Compounds › Tirzepatide · 16 Nov 2025 · 0 likes Reframing tirzepatide titration schedules slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen",…
Interpreting a result that disagrees with the supplier's certificate Replied, post #8 · Sourcing › Independent verification · 8 Nov 2025 · 3 likes Understood, and I withdraw the assumption I opened with.
What pooling buys you and what it destroys Replied, post #58 · Evidence › Meta-analyses · 4 Nov 2025 · 16 likes On pooling buys the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Early satiety becoming a problem rather than a benefit Replied, post #5 · Practice › Side effects · 2 Nov 2025 · 26 likes Summarising the early satiety thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…
The headache that turns out to be dehydration Replied, post #40 · Nutrition & Training › Hydration & electrolytes · 31 Oct 2025 · 22 likes On headache, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting…
Documentation that materially improves an appeal's chances Replied, post #38 · Access › Insurance & coverage · 24 Oct 2025 · 3 likes Careful with the language on documentation. "Not detected" and "not present" are different findings and the first is a statement about the method.
NHS criteria and how they are applied in practice — the long version Replied, post #5 · Regional › UK & Ireland · 14 Sep 2025 · 7 likes Correcting an out-of-date claim in this subcategory with a source and a date is more valuable than a new topic on the same question. Genuinely open to being wrong about…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #25 · Analytics › Method validation · 13 Sep 2025 · 0 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
Trial registration and comparing the protocol with the paper Replied, post #37 · Evidence › Trials · 11 Sep 2025 · 23 likes Taking post #34 at face value and following it one step further. Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #90 · Data & Tools › Datasets · 9 Sep 2025 · 18 likes I came in to disagree and I am leaving without a disagreement.
Insurance and replacement policies, compared — the long version Replied, post #13 · Sourcing › Logistics · 7 Sep 2025 · 20 likes A tracking gap at a customs facility is the most common cause of an unexpectedly long transit and the segment nobody has visibility of. That is the version I would…
A preprint whose numbers changed substantially at publication Replied, post #40 · Evidence › Preprints · 3 Sep 2025 · 1 like Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #104 · Data & Tools › Calculators · 3 Sep 2025 · 14 likes Rounding behaviour is where two tools disagree. One rounding to the nearest graduation and one to two decimal places will produce different advice from identical inputs.
Second pass at: A history of disordered eating: proceeding carefully Replied, post #123 · Wellbeing › Mental health · 1 Sep 2025 · 1 like Helpful, and short, which on this subject is harder than long.
What this community means by "a source", in practical terms Replied, post #94 · Start Here › Welcome · 31 Aug 2025 · 0 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #22 · Practice › Side effects · 28 Aug 2025 · 0 likes Picking up post #19: that is the part I would want checked first. Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #8 · Lounge › Off topic · 27 Aug 2025 · 0 likes Lounge question, no agenda: does anyone else keep a physical notebook for this rather than a file? Mine is more use than anything I have typed, and I cannot entirely…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #27 · Compounds › Other compounds · 25 Aug 2025 · 6 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #116 · Wellbeing › Mental health · 22 Aug 2025 · 8 likes Worth separating two things that post #112 runs together. Support and community: some people process weight change through community (online or in-person). Others…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #20 · Analytics › COA interpretation · 14 Aug 2025 · 2 likes Post #16 describes the usual case. This is about the unusual one. When a document puts the specification in the result column, it has told you the release criterion,…
Coming back to: What published stability data actually covers, and what it does not Replied, post #112 · Practice › Storage & stability · 13 Aug 2025 · 15 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
Temperature loggers worth the money Replied, post #16 · Devices › Cold chain · 7 Aug 2025 · 13 likes A phase-change pack holds a defined temperature while it changes state and then behaves like anything else. A gel pack starts cold and warms continuously. They are…
Pooling trials with different estimands — what changed since Replied, post #10 · Evidence › Meta-analyses · 5 Aug 2025 · 3 likes Individual participant data pooling is a much stronger design than aggregate pooling and is rare because it requires cooperation rather than a search. That is the…
Reading a supplier's product description as a marketing document Replied, post #53 · Compounds › Other compounds · 4 Aug 2025 · 17 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #67 · Data & Tools › Calculators · 30 Jul 2025 · 0 likes On post #64 — agreed on the reasoning, with one qualification. Two claims get bundled together under titration planner refuses and they need separating. The descriptive…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #38 · Data & Tools › Calculators · 30 Jun 2025 · 1 like Where I part company with post #36, and it is a narrow parting. Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel…
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #67 · Compounds › Other compounds · 16 Jun 2025 · 3 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
Sodium, potassium and magnesium when intake drops Replied, post #2 · Nutrition & Training › Hydration & electrolytes · 31 May 2025 · 6 likes The opening post and I disagree about the size of the effect, not about the direction. The very ordinary causes of week-two malaise: inadequate hydration, low sodium…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #120 · Sourcing › Independent verification · 19 May 2025 · 6 likes Where the Janoshik reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Second pass at: Designing a personal experiment that could change your mind Replied, post #3 · Research Methods › N-of-1 designs · 16 May 2025 · 29 likes Coming back to the opening post, because the follow-up matters more than the original answer. The most useful reply I ever got about Designing a personal experiment was…
Follow-up: Documentation that appears only after payment Replied, post #67 · Sourcing › Red flags · 11 May 2025 · 0 likes The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at scale.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #81 · Compounds › Tirzepatide · 10 May 2025 · 13 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #57 · Compounds › Secretagogues & GH axis · 7 May 2025 · 16 likes Helpful, and easy to find again, which is half of what a good reply is.
Shakes versus food: a pragmatic assessment — the long version Replied, post #11 · Nutrition & Training › Protein & intake · 28 Apr 2025 · 7 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Shakes versus food, because it is the sort of subject where it…
Reading a supplier's product description as a marketing document Replied, post #17 · Compounds › Other compounds · 28 Apr 2025 · 30 likes That reframing is the whole thing. The facts I already had.
Talking to a therapist about this specifically — does this still hold? Replied, post #52 · Wellbeing › Mental health · 28 Apr 2025 · 1 like Nothing here is medical advice and several members in this subcategory say plainly that they are describing their own experience only.
Reconstituting a multi-strength kit without mixing yourself up Replied, post #58 · Practice › Reconstitution · 16 Apr 2025 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
The C-cell question: rodent findings and their human context Replied, post #3 · Compounds › Semaglutide · 26 Mar 2025 · 12 likes On the "does it stop working" question: tolerance in the pharmacological sense is not what the withdrawal trials show. What they show is that the effect persists while…
Counter-ion form: the field almost nobody reports — one year on Replied, post #104 · Analytics › COA interpretation · 20 Mar 2025 · 0 likes Narrowing post #103, because the general version has more than one answer. The fields that make one usable: lot identifier matching the container, test date, method…
Charge states for a 4 kDa peptide, worked through Replied, post #135 · Analytics › Mass spectrometry · 17 Mar 2025 · 29 likes Right, and stated more narrowly than I would have dared to state it.
Research-use-only labelling: what it means and what it does not — the long version Replied, post #101 · Sourcing › Regulatory · 9 Mar 2025 · 14 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post.
Prior authorisation: what the criteria usually require Replied, post #13 · Access › Insurance & coverage · 6 Mar 2025 · 0 likes The arithmetic on prior authorisation is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
Biased agonism: a real phenomenon, an over-used explanation Replied, post #48 · Pharmacology › Receptor biology · 6 Mar 2025 · 0 likes Answering the question post #47 raises rather than the one it answers. Adding a reference point for biased agonism. Mine is a single case, collected without controls,…
Talking to a therapist about this specifically — does this still hold? Replied, post #23 · Wellbeing › Mental health · 28 Feb 2025 · 11 likes The social side of this — how other people respond to visible change — comes up constantly and has nothing to do with pharmacology.
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #13 · Compounds › Secretagogues & GH axis · 20 Feb 2025 · 21 likes I would put moderate confidence on the mainstream reading of Tesamorelin and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
Consistent declarations and why they matter more than clever ones Replied, post #53 · Sourcing › Logistics · 19 Feb 2025 · 32 likes One caution on consistent declarations: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely…
When to suspect the method rather than the sample Replied, post #78 · Analytics › Method validation · 7 Feb 2025 · 6 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. Adding…
SURPASS-2 and the comparator dose question that will not go away Replied, post #103 · Compounds › Tirzepatide · 12 Jan 2025 · 1 like Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
Recovery when intake is low: what to cut first Replied, post #20 · Nutrition & Training › Resistance training · 10 Jan 2025 · 16 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
Follow-up: Individual participant data versus aggregate data Replied, post #42 · Evidence › Meta-analyses · 9 Jan 2025 · 27 likes Post #41 is right about the mechanism and I think understates the practical bit. Double extraction with disagreement resolution is standard and is worth checking for,…
The topic list is dense — is that deliberate? Replied, post #76 · Meta › Site feedback · 2 Jan 2025 · 21 likes Feedback on the trust-level page: it explains what each level unlocks, and not what a member at that level is expected to do differently. The second is what people…
A promotion I argued against, and why I lost Replied, post #42 · Documentation › Doc review · 27 Dec 2024 · 5 likes Summarising the promotion thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is…
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #15 · Compounds › Tirzepatide · 20 Dec 2024 · 0 likes The published pharmacokinetics show dose proportionality across the studied range, which means dose arithmetic behaves the way you would naively expect. That is not…
Micronutrient status when intake falls substantially — a second dataset Replied, post #6 · Clinical › Bloodwork · 14 Dec 2024 · 0 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
Why "any advice?" is the least effective ending for a post Replied, post #111 · Start Here › How to Ask · 6 Dec 2024 · 1 like Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #41 · Evidence › Journal club · 24 Nov 2024 · 3 likes Worth stating the null on SURPASS-2 before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
UK access routes, dated and sourced — a second dataset Replied, post #3 · Regional › UK & Ireland · 29 Oct 2024 · 4 likes This follows the opening post rather than contradicting it. Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #113 · Clinical › Bloodwork · 16 Oct 2024 · 7 likes I had written a reply contradicting post #111 and deleted it. Here is what survived. The strongest argument against my own position on bring a laboratory, stated as…
Why a preprint's supplementary material is often the best part Replied, post #21 · Evidence › Preprints · 12 Sep 2024 · 3 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
Chronic kidney disease and the FLOW result Replied, post #27 · Clinical › Comorbidities · 19 Aug 2024 · 0 likes What I would tell a new member reading about chronic kidney disease for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #7 · Evidence › Journal club · 31 Jul 2024 · 17 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
Second pass at: Journal club: LEADER as the historical anchor Replied, post #69 · Evidence › Journal club · 26 Jul 2024 · 18 likes Offering a way to settle LEADER rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise,…
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #2 · Safety › Contraindications · 11 Jul 2024 · 19 likes I keep a log for Conditions specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
Cold packs, phase-change material, and what survives ten days Replied, post #36 · Sourcing › Logistics · 23 Jun 2024 · 22 likes Where I part company with post #33, and it is a narrow parting. Marking my uncertainty on cold packs explicitly. I am confident about the direction, much less confident…
The mass-error checker and its intended scope Replied, post #52 · Data & Tools › Calculators · 15 Jun 2024 · 2 likes Post #48 and I disagree about the size of the effect, not about the direction. Whatever the answer on mass-error checker turns out to be, the method for getting there…